Cosmetic cross-reference

(-)-Epicatechin

CAS 490-46-0

(-)-Epicatechin (CAS 490-46-0) is a Phase 2 pharmaceutical compound with 9 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
9
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
1
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
(-)-Epicatechin
CAS Number
490-46-0
UNII
34PHS7TU43
InChIKey
PFTAWBLQPZVEMU-UKRRQHHQSA-N
ChEMBL ID
CHEMBL583912
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2
Mid-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL583912 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 9 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 119733.125 nM 40 -
- Potency 21156.129032258064 nM 25 -
- MIC 118.2 ug.mL-1 20 -
- IC50 20.208000000000002 ug.mL-1 15 -
- EC50 33680.4 nM 5 -
- AC50 15458.112500000001 nM 4 -
- Ki 66733.33333333333 nM 3 -
- Kd 39950 nM 2 -
- MIC 1000000 nM 1 -
SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
TAS2R39
TAS2R39
Agonist 3.380000114440918 pEC50 21272567
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is (-)-Epicatechin used for in pharmaceutical contexts?

(-)-Epicatechin (CAS 490-46-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for (-)-Epicatechin?

No adverse-event association or SIDER side-effect rows are rendered for (-)-Epicatechin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is (-)-Epicatechin also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Epicatechin with EU status "permitted".

What clinical phase is (-)-Epicatechin in?

(-)-Epicatechin is rendered with ChEMBL max phase 2.